Egrifta (Tesamorelin) and Acetaminophen Interaction
Clinical review of the tesamorelin and acetaminophen drug interaction, including hepatic metabolism overlap, CYP enzyme effects, monitoring recommendations, and dose guidance.
Tesamorelin: Drug Interactions
30 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
30articles
3topic areas covered
May 26, 2026latest review
Tesamorelin: Drug Interactions library
Showing 30 of 30 clinical reviews.
Egrifta (Tesamorelin) and Apixaban Interaction: Safety, Mechanism, and Clinical Guidance
Clinical review of the tesamorelin-apixaban drug interaction covering CYP3A4/P-gp mechanism, severity rating, monitoring parameters, and dose-adjustment guidance.
Egrifta (Tesamorelin) and Atorvastatin Interaction: What You Need to Know
A physician-reviewed guide to the tesamorelin and atorvastatin drug interaction, covering mechanism, severity, monitoring parameters, dose considerations, and patient counseling for HIV-associated lipodystrophy.
Egrifta (Tesamorelin) and Benzodiazepines Interaction: What Patients and Clinicians Need to Know
A physician-reviewed guide to the tesamorelin, benzodiazepine drug interaction, covering mechanism, severity, monitoring parameters, dose considerations, and patient counseling for HIV-associated lipodystrophy.
Egrifta (Tesamorelin) and Bupropion Interaction: What Patients and Clinicians Need to Know
A physician-reviewed guide to the tesamorelin and bupropion drug interaction, covering mechanism, seizure risk, CYP2D6 considerations, monitoring protocols, and dose-adjustment strategies.
Egrifta (Tesamorelin) and Clopidogrel Interaction: What You Need to Know
Clinical analysis of the tesamorelin-clopidogrel drug interaction, covering CYP enzyme pathways, cardiovascular risk in HIV lipodystrophy, monitoring protocols, and dose-adjustment guidance.
Egrifta (Tesamorelin) and Diphenhydramine Interaction: What You Need to Know
A clinician-level review of the tesamorelin and diphenhydramine drug interaction, covering mechanism, severity, GH-axis effects, anticholinergic overlap, monitoring parameters, and patient counseling for HIV-associated lipodystrophy management.
Egrifta (Tesamorelin) and Estradiol HRT Interaction: Safety, Risks, and Clinical Guidance
What is known and unknown about using tesamorelin with estradiol, including label-based risks, growth-hormone biology, and questions for the prescribing team.
Egrifta (Tesamorelin) and Finasteride Interaction: What Patients and Clinicians Need to Know
A board-reviewed clinical guide covering the pharmacokinetic and pharmacodynamic interaction between tesamorelin (Egrifta) and finasteride, including mechanism, severity, monitoring parameters, and patient counseling points.
Egrifta (Tesamorelin) and Gabapentin Interaction: What Patients and Clinicians Need to Know
A physician-reviewed guide to the tesamorelin, gabapentin drug interaction: mechanism, severity, monitoring parameters, dose considerations, and patient counseling for HIV-associated lipodystrophy.
Egrifta (Tesamorelin) and Hormonal Contraceptives: Interaction Guide
A physician-reviewed guide to the tesamorelin and hormonal contraceptives drug interaction, covering mechanism, clinical severity, monitoring, dose adjustments, and patient counseling based on FDA labeling and primary literature.
Egrifta (Tesamorelin) and Levothyroxine Interaction: Safety, Monitoring, and Dose Adjustment
Clinical guide to the tesamorelin-levothyroxine interaction covering mechanism, severity, monitoring parameters, dose adjustment, and patient counseling with cited evidence.
Egrifta (Tesamorelin) and Metformin Interaction: What Patients and Clinicians Need to Know
A detailed clinical review of the tesamorelin-metformin drug interaction, covering pharmacodynamic mechanism, glucose monitoring, dose adjustment, and patient counseling for HIV-associated lipodystrophy.
Egrifta (Tesamorelin) and NSAIDs (Ibuprofen, Naproxen) Interaction
Clinical guide to combining tesamorelin (Egrifta) with NSAIDs like ibuprofen and naproxen. Covers pharmacokinetic and pharmacodynamic overlap, monitoring recommendations, and dose-adjustment considerations for patients with HIV-associated lipodystrophy.
Egrifta (Tesamorelin) and Opioids (Oxycodone, Hydrocodone, Tramadol): What You Need to Know
A physician-reviewed guide to the tesamorelin, opioid drug interaction, covering mechanism, severity, monitoring parameters, dose-adjustment considerations, and patient counseling for oxycodone, hydrocodone, and tramadol.
Egrifta (Tesamorelin) and PPIs (Omeprazole, Pantoprazole): Drug Interaction Guide
A clinical deep-dive into the tesamorelin-PPI interaction: mechanism, severity, monitoring parameters, dose adjustments, and patient counseling backed by FDA labeling and primary literature.
Egrifta (Tesamorelin) and Prednisone Interaction: What Clinicians and Patients Should Know
A clinical review of the pharmacodynamic interaction between tesamorelin (Egrifta) and prednisone, covering glucose risk, body composition, bone effects, monitoring protocols, and dose-adjustment guidance.
Egrifta (Tesamorelin) and Pregabalin Interaction: What Clinicians and Patients Need to Know
A physician-reviewed guide to the tesamorelin and pregabalin drug interaction: mechanism, severity, monitoring parameters, dose-adjustment considerations, and patient counseling points.
Egrifta (Tesamorelin) and Progesterone HRT Interaction: What Patients and Clinicians Need to Know
A detailed clinical review of the tesamorelin, progesterone HRT drug interaction, covering mechanism, severity, monitoring, dose adjustment, and patient counseling backed by primary literature and FDA labeling.
Egrifta (Tesamorelin) and Rivaroxaban Interaction: Safety, Risks, and Clinical Guidance
Can you take Egrifta (tesamorelin) with rivaroxaban? A physician-reviewed guide covering CYP3A4 mechanisms, severity ratings, monitoring protocols, and dose-adjustment considerations.
Egrifta (Tesamorelin) and Rosuvastatin Interaction: What Patients and Clinicians Need to Know
A clinician-level review of the tesamorelin, rosuvastatin drug interaction: mechanism, severity, monitoring parameters, dose adjustments, and patient counseling for HIV-associated lipodystrophy.
Egrifta (Tesamorelin) and Sildenafil Interaction: Safety, Mechanisms, and Clinical Guidance
Is it safe to take Egrifta (tesamorelin) with sildenafil? A physician-reviewed guide covering drug interaction mechanisms, monitoring requirements, dose adjustments, and clinical evidence for combining these medications.
Egrifta (Tesamorelin) and Simvastatin Interaction: What Patients and Clinicians Need to Know
A clinician-reviewed guide to the tesamorelin, simvastatin drug interaction, covering CYP3A4 mechanisms, rhabdomyolysis risk, IGF-1 monitoring, dose adjustment, and patient counseling for HIV-associated lipodystrophy.
Egrifta (Tesamorelin) and SNRIs (Venlafaxine, Duloxetine): Drug Interaction Guide
A clinician-level review of the tesamorelin, SNRI interaction covering mechanism, pharmacokinetics, serotonin-syndrome risk, blood-pressure effects, monitoring parameters, and patient counseling for safe co-administration.
Egrifta (Tesamorelin) and SSRIs (Sertraline, Escitalopram): Drug Interaction Guide
Can you take tesamorelin with SSRIs like sertraline or escitalopram? Review the pharmacokinetic and pharmacodynamic evidence, monitoring protocols, and clinical guidance for this combination.
Egrifta (Tesamorelin) and Tadalafil Interaction: Safety, Risks, and Clinical Guidance
Can you take Egrifta (tesamorelin) with tadalafil? A physician-reviewed guide covering pharmacokinetic and pharmacodynamic interactions, monitoring protocols, and dose-adjustment considerations.
Egrifta (Tesamorelin) and Testosterone Interaction: What Patients and Clinicians Need to Know
A physician-reviewed guide to the tesamorelin, testosterone drug interaction: mechanisms, polycythemia risk, lipid monitoring, dose considerations, and patient counseling backed by primary literature.
Egrifta (Tesamorelin) and Trazodone Interaction: Safety, Risks, and Clinical Guidance
What current labeling and interaction resources establish about tesamorelin with trazodone, what remains unknown, and which patient-specific risks require review.
Egrifta (Tesamorelin) and Warfarin Interaction: What Patients and Clinicians Need to Know
A clinician-level review of the tesamorelin-warfarin drug interaction: mechanism, INR monitoring, dose adjustment, and patient counseling backed by FDA labeling and primary literature.
Egrifta (Tesamorelin) and Zolpidem Interaction: What Clinicians and Patients Should Know
A clinical review of the tesamorelin (Egrifta) and zolpidem drug interaction, covering pharmacokinetic and pharmacodynamic mechanisms, severity rating, monitoring parameters, dose adjustments, and patient counseling.